|
1
|
Wu F, Zhao S, Yu B, Chen YM, Wang W, Song
ZG, Hu Y, Tao ZW, Tian JH, Pei YY, et al: A new coronavirus
associated with human respiratory disease in China. Nature.
579:265–269. 2020.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Chakraborty C, Sharma AR, Sharma G,
Bhattacharya M and Lee SS: SARS-CoV-2 causing pneumonia-associated
respiratory disorder (COVID-19): Diagnostic and proposed
therapeutic options. Eur Rev Med Pharmacol Sci. 24:4016–4026.
2020.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Liu X, Liu C, Liu G, Luo W and Xia N:
COVID-19: Progress in diagnostics, therapy and vaccination.
Theranostics. 10:7821–7835. 2020.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Samavati L and Uhal BD: ACE2, much more
than just a receptor for SARS-COV-2. Front Cell Infect Microbiol.
10(317)2020.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Yan R, Zhang Y, Li Y, Xia L, Guo Y and
Zhou Q: Structural basis for the recognition of SARS-CoV-2 by
full-length human ACE2. Science. 367:1444–1448. 2020.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Hoffmann M, Kleine-Weber H, Schroeder S,
Krüger N, Herrler T, Erichsen S, Schiergens TS, Herrler G, Wu NH,
Nitsche A, et al: SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2
and is blocked by a clinically proven proteaseinhibitor. Cell.
181:271–280.e8. 2020.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Roca-Ho H, Riera M, Palau V, Pascual J and
Soler MJ: Characterization of ACE and ACE2 expression within
different organs of the NOD mouse. Int J Mol Sci.
18(563)2017.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Das UN: Renin-angiotensin-aldosterone
system in insulin resistance and metabolic syndrome. J Transl Int
Med. 4:66–72. 2016.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Kato H, Hou J, Chobanian AV and Brecher P:
Effects of angiotensin II infusion and inhibition of nitric oxide
synthase on the rat aorta. Hypertension. 28:153–158.
1996.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Santos RA, Simoese Silva AC, Maric C,
Silva DM, Machado RP, de Buhr I, Heringer-Walther S, Pinheiro SV,
Lopes MT, Bader M, et al: Angiotensin-(1-7) is an endogenous ligand
for the G protein-coupled receptor Mas. Proc Natl Acad Sci USA.
100:8258–8263. 2003.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Fraga-Silva RA, Sorg BS, Wankhede M,
Dedeugd C, Jun JY, Baker MB, Li Y, Castellano RK, Katovich MJ,
Raizada MK, et al: ACE2 activation promotes antithrombotic
activity. Mol Med. 16:210–215. 2010.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Tikellis C and Thomas MC:
Angiotensin-converting enzyme 2 (ACE2) is a key modulator of the
renin angiotensin system in health and disease. Int J Pept.
2012(256294)2012.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Wang Z and Xu X: scRNA-seq profiling of
human testes reveals the presence of the ACE2 receptor, a target
for SARS-CoV-2 infection in Spermatogonia, Leydig and Sertoli
cells. Cells. 9(920)2020.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Illiano E, Trama F and Costantini E: Could
COVID-19 have an impact on male fertility? Andrologia.
52(e13654)2020.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Li D, Jin M, Bao P, Zhao W and Zhang S:
Clinical characteristics and results of semen tests among men with
coronavirus disease 2019. JAMA Netw Open. 3(e208292)2020.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Holtmann N, Edimiris P, Andree M, Doehmen
C, Baston-Buest D, Adams O, Kruessel JS and Bielfeld AP: Assessment
of SARS-CoV-2 in human semen-a cohort study. Fertil Steril.
114:233–238. 2020.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Yang M, Chen S, Huang B, Zhong JM, Su H,
Chen YJ, Cao Q, Ma L, He J, Li XF, et al: Pathological findings in
the testes of COVID-19 patients: Clinical implications. Eur Urol
Focus. 6:1124–1129. 2020.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Lue TF: Erectile dysfunction. N Engl J
Med. 342:1802–1813. 2000.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Cai Z, Zhang J and Li H: Two birds with
one stone: Regular use of PDE5 inhibitors for treating male
patients with erectile dysfunction and cardiovascular diseases.
Cardiovasc Drugs Ther. 33:119–128. 2019.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Tay MZ, Poh CM, Rénia L, MacAry PA and Ng
LF: The trinity of COVID-19: Immunity, inflammation and
intervention. Nat Rev Immunol. 20:363–374. 2020.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Karakhanova S, Yang Y, Link J, Soltek S,
von Ahn K, Umansky V, Werner J and Bazhin AV: Gender-specific
immunological effects of the phosphodiesterase 5 inhibitor
sildenafil in healthy mice. Mol Immunol. 56:649–659.
2013.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Szczypka M and Obmińska-Mrukowicz B:
Modulating effects of nonselective and selective phosphodiesterase
inhibitors on lymphocyte subsets and humoral immune response in
mice. Pharmacol Rep. 62:1148–1158. 2010.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Szczypka M and Obmińska-Mrukowicz B: The
effects of selective and nonselective phosphodiesterase inhibitors
on phagocytic cells in mice. Immunopharmacol Immunotoxicol.
32:507–513. 2010.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Pifarré P, Gutierrez-Mecinas M, Prado J,
Usero L, Roura-Mir C, Giralt M, Hidalgo J and García A:
Phosphodiesterase 5 inhibition at disease onset prevents
experimental autoimmune encephalomyelitis progression through
immunoregulatory and neuroprotective actions. Exp Neurol.
251:58–71. 2014.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Serafini P, Meckel K, Kelso M, Noonan K,
Califano J, Koch W, Dolcetti L, Bronte V and Borrello I:
Phosphodiesterase-5 inhibition augments endogenous antitumor
immunity by reducing myeloid-derived suppressor cell function. J
Exp Med. 203:2691–2702. 2006.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Meyer C, Sevko A, Ramacher M, Bazhin AV,
Falk CS, Osen W, Borrello I, Kato M, Schadendorf D, Baniyash M, et
al: Chronic inflammation promotes myeloid-derived suppressor cell
activation blocking antitumor immunity in transgenic mouse melanoma
model. Proc Natl Acad Sci USA. 108:17111–17116. 2011.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Jerzak M, Kniotek M, Mrozek J, Górski A
and Baranowski W: Sildenafil citrate decreased natural killer cell
activity and enhanced chance of successful pregnancy in women with
a history of recurrent miscarriage. Fertil Steril. 90:1848–1853.
2008.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Sarfati M, Mateo V, Baudet S, Rubio M,
Fernandez C, Davi F, Binet JL, Delic J and Merle-Beral H:
Sildenafil and vardenafil, types 5 and 6 phosphodiesterase
inhibitors, induce caspase-dependent apoptosis of B-chronic
lymphocytic leukemia cells. Blood. 101:265–269. 2003.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Kniotek M and Boguska A: Sildenafil can
affect innate and adaptive immune system in both experimental
animals and patients. J Immunol Res. 2017(4541958)2017.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Lubamba B, Huaux F, Lebacq J, Marbaix E,
Dhooghe B, Panin N, Wallemacq P and Leal T: Immunomodulatory
activity of vardenafil on induced lung inflammation in cystic
fibrosis mice. J Cyst Fibros. 11:266–273. 2012.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Huaux F, Noel S, Dhooghe B, Panin N, Lo Re
S, Lison D, Wallemacq P, Marbaix E, Scholte BJ, Lebecque P, et al:
Dysregulated proinflammatory and fibrogenic phenotype of
fibroblasts in cystic fibrosis. PLoS One. 8(e64341)2013.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Zhu CY, Liu M, Liu YZ, Li W, Zhai W, Che
JP, Yan Y, Wang GC and Zheng JH: Preventive effect of
phosphodiesterase 5 inhibitor tadalafil on experimental
post-pyelonephritic renal injury in rats. J Surg Res. 186:253–261.
2014.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Kosutova P, Mikolka P, Balentova S,
Kolomaznik M, Adamkov M, Mokry J, Calkovska A and Mokra D: Effects
of phosphodiesterase 5 inhibitor sildenafil on the respiratory
parameters, inflammation and apoptosis in a saline lavage-induced
model of acute lung injury. J Physiol Pharmacol. 69:2018.PubMed/NCBI View Article : Google Scholar
|
|
34
|
de Visser YP, Walther FJ, Laghmani H,
Boersma H, van der Laarse A and Wagenaar GT: Sildenafil attenuates
pulmonary inflammation and fibrin deposition, mortality and right
ventricular hypertrophy in neonatal hyperoxic lung injury. Respir
Res. 10(30)2009.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Abdelaziz RR, Elkashef WF and Said E:
Tadalafil reduces airway hyperactivity and protects against lung
and respiratory airways dysfunction in a rat model of silicosis.
Int Immunopharmacol. 40:530–541. 2016.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Cadirci E, Halici Z, Odabasoglu F,
Albayrak A, Karakus E, Unal D, Atalay F, Ferah I and Unal B:
Sildenafil treatment attenuates lung and kidney injury due to
overproduction of oxidant activity in a rat model of sepsis: A
biochemical and histopathological study. Clin Exp Immunol.
166:374–384. 2011.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Köktürk S, Benli E, Ayyıldız A, Cırrık S,
Çetinkol Y, Ayyıldız SN and Noyan T: Positive outcomes of
phosphodiesterase type 5 inhibitor on histopathologic and
biochemical changes induced by ureteral obstruction. Rev Assoc Med
Bras (1992). 65:388–393. 2019.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Di Luigi L, Corinaldesi C, Colletti M,
Scolletta S, Antinozzi C, Vannelli GB, Giannetta E, Gianfrilli D,
Isidori AM, Migliaccio S, et al: Phosphodiesterase type 5 inhibitor
sildenafil decreases the proinflammatory chemokine CXCL10 in human
cardiomyocytes and in subjects with diabetic cardiomyopathy.
Inflammation. 39:1238–1252. 2016.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Bakhsh A, Daqqaq T, Alhasan A, Alnazari M
and Rajih E: The role of phosphodiesterase inhibitors in the
management of cavernositis with multifocal abscesses: A report of
case series. Sex Med. 8:318–322. 2020.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Aliaev IuG, Vinarov AZ and Akhvlediani ND:
Wardenafil in combined treatment of patients with chronic bacterial
prostatitis. Urologiia. 6:52–55. 2008.PubMed/NCBI(In Russian).
|
|
41
|
Davenport C and Dubin A: Tadalafil therapy
and severe chronic foot wound resolution. Int Wound J. 12:733–736.
2015.PubMed/NCBI View Article : Google Scholar
|
|
42
|
Kovalski V, Prestes AP, Oliveira JG, Alves
GF, Colarites DF, Mattos JE, Sordi R, Vellosa JC and Fernandes D:
Protective role of cGMP in early sepsis. Eur J Pharmacol.
807:174–181. 2017.PubMed/NCBI View Article : Google Scholar
|
|
43
|
Ayten R, Cetinkaya Z, Girgin M, Ozercan I,
Ustundag B and Aygen E: The effects of intraperitoneal sildenafil
administration on healing of left colonic anastomoses and
intra-abdominal adhesion formation in the presence of
intra-abdominal infection. Dis Colon Rectum. 51:1837–1841.
2008.PubMed/NCBI View Article : Google Scholar
|
|
44
|
Hosgood SA, Randle LV, Patel M, Watson CJ,
Bradley JA and Nicholson ML: Sildenafil citrate in a donation after
circulatory death experimental model of renal ischemia-reperfusion
injury. Transplantation. 98:612–617. 2014.PubMed/NCBI View Article : Google Scholar
|
|
45
|
Korom S, Hillinger S, Cardell M, Zhai W,
Tan Q, Dutly A, Leskosek B and Weder W: Sildenafil extends survival
and graft function in a large animal lung transplantation model.
Eur J Cardiothorac Surg. 29:288–293. 2006.PubMed/NCBI View Article : Google Scholar
|
|
46
|
Amano T, Earle C, Imao T, Matsumoto Y and
Kishikage T: Administration of daily 5 mg tadalafil improves
endothelial function in patients with benign prostatic hyperplasia.
Aging Male. 21:77–82. 2018.PubMed/NCBI View Article : Google Scholar
|
|
47
|
Andrigueti FV, Ebbing PCC, Arismendi MI
and Kayser C: Evaluation of the effect of sildenafil on the
microvascular blood flow in patients with systemic sclerosis: A
randomised, double-blind, placebo-controlled study. Clin Exp
Rheumatol. 35 (Suppl 106):151–158. 2017.PubMed/NCBI
|
|
48
|
Thieme M, Sivritas SH, Mergia E, Potthoff
SA, Yang G, Hering L, Grave K, Hoch H, Rump LC and Stegbauer J:
Phosphodiesterase 5 inhibition ameliorates angiotensin II-dependent
hypertension and renal vascular dysfunction. Am J Physiol Renal
Physiol. 312:F474–F481. 2017.PubMed/NCBI View Article : Google Scholar
|
|
49
|
Aydin S, Kuloglu T, Aydin S, Yardim M,
Azboy D, Temizturk Z, Kalkan AK and Eren MN: The effect of iloprost
and sildenafil, alone and in combination, on myocardial ischaemia
and nitric oxide and irisin levels. Cardiovasc J Afr. 28:389–396.
2017.PubMed/NCBI View Article : Google Scholar
|
|
50
|
Santi D, Granata AR, Guidi A, Pignatti E,
Trenti T, Roli L, Bozic R, Zaza S, Pacchioni C, Romano S, et al:
Six months of daily treatment with vardenafil improves parameters
of endothelial inflammation and of hypogonadism in male patients
with type 2 diabetes and erectile dysfunction: A randomized,
double-blind, prospective trial. Eur J Endocrinol. 174:513–522.
2016.PubMed/NCBI View Article : Google Scholar
|
|
51
|
Valatsou A, Briasoulis A, Vogiatzi G,
Pantopoulou A, Oikonomou E, Miliou A, Perrea D and Tousoulis D:
Beneficial effects of sildenafil on tissue perfusion and
inflammation in a murine model of limb ischemia and
atherosclerosis. Curr Vasc Pharmacol. 15:282–287. 2017.PubMed/NCBI View Article : Google Scholar
|
|
52
|
Sheng M, Lu H, Liu P, Li Y, Ravi H, Peng
SL, Diaz-Arrastia R, Devous MD and Womack KB: Sildenafil improves
vascular and metabolic function in patients with Alzheimer's
disease. J Alzheimers Dis. 60:1351–1364. 2017.PubMed/NCBI View Article : Google Scholar
|
|
53
|
Palma G, Giordano R, Russolillo V, Cioffi
S, Palumbo S, Mucerino M, Poli V and Vosa C: Sildenafil therapy for
pulmonary hypertension before and after pediatric congenital heart
surgery. Tex Heart Inst J. 38:238–242. 2011.PubMed/NCBI
|
|
54
|
Kelly LE, Ohlsson A and Shah PS:
Sildenafil for pulmonary hypertension in neonates. Cochrane
Database Syst Rev. 8(CD005494)2017.PubMed/NCBI View Article : Google Scholar
|
|
55
|
Mondaini N: Phosphodiesterase type 5
inhibitors and COVID-19: are they useful in disease management?
World J Mens Health. 38:254–255. 2020.PubMed/NCBI View Article : Google Scholar
|
|
56
|
Dal Moro F and Livi U: Any possible role
of phosphodiesterase type 5 inhibitors in the treatment of severe
COVID19 infections? A lesson from urology. Clin Immunol.
214(108414)2020.PubMed/NCBI View Article : Google Scholar
|
|
57
|
Solaimanzadeh I: Acetazolamide, nifedipine
and phosphodiesterase inhibitors: Rationale for their utilization
as adjunctive countermeasures in the treatment of coronavirus
disease 2019 (COVID-19). Cureus. 12(e7343)2020.PubMed/NCBI View Article : Google Scholar
|
|
58
|
Dal Moro F, Vendramin I and Livi U: The
war against the SARS-CoV2 infection: Is it better to fight or
mitigate it? Med Hypotheses. 143(110129)2020.PubMed/NCBI View Article : Google Scholar
|
|
59
|
Reinert JP and Reinert NJ: The role of
phosphodiesterase-5 inhibitors in COVID-19: An exploration of
literature from similar pathologies. J Intensive Care Med. 36:3–8.
2020.PubMed/NCBI View Article : Google Scholar
|
|
60
|
Groner MF, de Carvalho RC, Camillo J,
Ferreira PR and Fraietta R: Effects of Covid-19 on male
reproductive system. Int Braz J Urol. 47:185–190. 2021.PubMed/NCBI View Article : Google Scholar
|
|
61
|
Batiha O, Al-Deeb T, Al-Zoubi E and
Alsharu E: Impact of COVID-19 and other viruses on reproductive
health. Andrologia. 52(e13791)2020.PubMed/NCBI View Article : Google Scholar
|
|
62
|
Shen Q, Xiao X, Aierken A, Yue W, Wu X,
Liao M and Hua J: The ACE2 expression in Sertoli cells and germ
cells may cause male reproductive disorder after SARS-CoV-2
infection. J Cell Mol Med. 24:9472–9477. 2020.PubMed/NCBI View Article : Google Scholar
|
|
63
|
Pan F, Xiao X, Guo J, Song Y, Li H, Patel
DP, Spivak AM, Alukal JP, Zhang X, Xiong C, et al: No evidence of
severe acute respiratory syndrome-coronavirus 2 in semen of males
recovering from coronavirus disease 2019. Fertil Steril.
113:1135–1139. 2020.PubMed/NCBI View Article : Google Scholar
|
|
64
|
Fraietta R, Pasqualotto FF, Roque M and
Taitson PF: SARS-COV-2 and male reproductive health. JBRA Assist
Reprod. 24:347–350. 2020.PubMed/NCBI View Article : Google Scholar
|
|
65
|
Khalili MA, Leisegang K, Majzoub A,
Finelli R, Panner Selvam MK, Henkel R, Mojgan M and Agarwal A: Male
fertility and the COVID-19 pandemic: Systematic review of the
literature. World J Mens Health. 38:506–520. 2020.PubMed/NCBI View Article : Google Scholar
|
|
66
|
Sofikitis N, Kaltsas A, Dimitriadis F,
Rassweiler J, Grivas N, Zachariou A, Kaponis A, Tsounapi P,
Paterakis N, Karagiannis A, et al: The Effect of PDE5 inhibitors on
the male reproductive tract. Curr Pharm Des: Feb 26, 2020 (Epub
ahead of print). doi: 10.2174/1381612826666200226121510.
|
|
67
|
Corvasce A, Albino G, Leonetti T, Buonomo
AF and Marucco EC: Once-a-day Tadalafil administration improves the
spermogram parameters in fertile patients. Arch Ital Urol Androl.
87:210–213. 2015.PubMed/NCBI View Article : Google Scholar
|
|
68
|
Yuan J, Zhang R, Yang Z, Lee J, Liu Y,
Tian J, Qin X, Ren Z, Ding H, Chen Q, et al: Comparative
effectiveness and safety of oral phosphodiesterase type 5
inhibitors for erectile dysfunction: A systematic review and
network meta-analysis. Eur Urol. 63:902–912. 2013.PubMed/NCBI View Article : Google Scholar
|
